Drug Type Small molecule drug |
Synonyms 3-O-caffeoylquinic-acid, 3-caffeoylquinic-acid, Coffee tannic acid + [1] |
Target |
Action inhibitors |
Mechanism DNMT1 inhibitors(DNA (cytosine-5)-methyltransferase 1 inhibitors), LAG3 inhibitors(Lymphocyte activation gene 3 protein inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (China) |
Molecular FormulaC16H18O9 |
InChIKeyCWVRJTMFETXNAD-NCZKRNLISA-N |
CAS Registry327-97-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Chlorogenic acid | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Lung Adenocarcinoma | Phase 1 | China | 12 Sep 2018 | |
Advanced Lung Small Cell Carcinoma | Phase 1 | China | 12 Sep 2018 | |
Kidney Neoplasms | Phase 1 | China | 24 Oct 2014 | |
Liver Cancer | Phase 1 | China | 24 Oct 2014 | |
Glioblastoma Multiforme | Preclinical | China | 27 Nov 2018 | |
Lung Cancer | Preclinical | China | 17 Jul 2018 | |
Non-squamous non-small cell lung cancer | Preclinical | China | 17 Jul 2018 | |
Small Cell Lung Cancer | Preclinical | China | 17 Jul 2018 | |
Locally Advanced Malignant Neoplasm | Preclinical | China | 01 Sep 2014 | |
Advanced cancer | Preclinical | - | 01 May 2014 |
Phase 2 | 30 | Placebo (Placebo) | (gypyxxwlet) = vqdffvrtvd tlmqtjspmb (cgopgdhtrc, angpfcufzz - oqshswwtde) View more | - | 02 Aug 2019 | ||
(Chlorogenic Acid) | (gypyxxwlet) = thzglhjxzr tlmqtjspmb (cgopgdhtrc, dtdkvjcnbx - fhrnwcmxwz) View more |